Spectra Plasmonics was founded by a team of scientists and engineers at Queen’s University in Kingston, Ontario. The core technology in Amplifi ID was backed by years of PhD research with the aim of creating a device that enables cost-effective, high-quality chemical analysis without complex lab steps. Our founding team was passionate about healthcare solutions and saw the potential impact our technology could make towards the drug-related challenges North America was facing.

 

Since our founding, we have worked with dozens of people combatting North America's drug overdose crisis to help create the optimal high performing drug checking solution for the front line.